HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW
HeartSciences Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.07+0.05 (+1.66%)
Close on Oct 19, 2026
- Market cap
- $11.26M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
−$0.26 (−7.81%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
HeartSciences Inc. reported revenue of $4.52K for the twelve months to Jul 31, 2026. Free cash flow was -$7.43M.
Revenue
$4.52K
TTM Q1 2027
Operating income
-$9.48M
TTM Q1 2027
Free cash flow
-$7.43M
FY2026
EPS, diluted
-$3.22
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $11.26M
- P/E ratio
- –
- Price to sales
- 2492.51
- Price to book
- –
- Dividend yield
- 0.00%
- Free cash flow yield
- -65.97%
Fundamentals
- Revenue
- $4.52K
- Net income
- -$10.26M
- EPS, diluted
- -$3.22
- Free cash flow
- -$7.43M
- Book value per share
- -$0.55
- Diluted shares
- 4M
Six years at a glance
Fiscal years 2021 to 2026 and trailing twelve months, USD
Revenue
$4.52K
Gross profit
$2.75K
Operating income
-$9.48M
Net income
-$10.26M
EPS, diluted
-$3.22
Free cash flow
–
Reported periodTrailing twelve months